This study was conducted to evaluate the protective efficacy of dietary Bacillus coagulans (B. coagulans) supplementation in birds receiving Salmonella enteritidis (SE). Two hundred and forty 1-day-old Cobb broilers were randomly assigned to 2 × 2 factorial arrangements of treatments with 2 levels of dietary B. coagulans (0 or 400 mg/kg) and 2 levels of SE challenge (0 or 1 × 10 9 SE between d 9 to 11). Results showed that SE infection did not affect growth performance, but caused intestinal inflammation and barrier function impairment by reducing intestinal goblet cells and beneficial bacteria numbers, increasing cecal Salmonella colonization and liver Salmonella invasion, downregulating jejunal mucin-2 (at 7 and 17 d post-infection, DPI), TLR2 (at 7 and 17 DPI), TLR4 (at 17 DPI), TNFSF15 (at 7 and 17 DPI) gene mRNA levels, and upregulating jejunal IFN-γ mRNA levels (at 17 DPI) compared to uninfected birds. Moreover, SE infection also elevated the concentration of jejunal anti-Salmonella IgA and sera antiSalmonella IgG compared to uninfected birds. However, chickens received B. coagulans diets showed significant increase in body weight gain and weight gain to feed intake ratio from d 15 to 21, alkaline phosphatase activity (at 7 DPI), cecal Lactobacilli and Bifidobacterium numbers (at 7 DPI; at 17 DPI), villous height: crypt ratio (at 17 DPI), and goblet cell numbers (at 7 and 17 DPI), whereas exhibiting reduced jejunal crypt depth (at 17 DPI), cecal Escherichia coli (at 7, 17, and 31 DPI), and Salmonella (at 7 and 17 DPI) levels compared with the non-supplemented birds, regardless of SE infection. In addition, B. coagulans supplement upregulated lysozyme mRNA levels (at 17 DPI), downregulated IFN-γ mRNA levels (at 7 and 17 DPI), showed an increased trend in Fowlicidin-2 mRNA levels (at 7 DPI) and a reduced trend in liver Salmonella load compared to the nonsupplemented control. These data indicated that B. coagulans has a protective effect in SE infected broilers.
INTRODUCTION
Salmonella enterica serotype Enteritidis (SE), a Gram-negative intracellular pathogen, is one of the most common serotypes of Salmonella bacteria reported worldwide and is the major source of human intestinal infections reported in recent years (Dunkley et al., 2009) . Infected chickens and contaminated poultry products are known to be one of the most important carriers of SE threatening human health (Vandeplas et al., 2010) . In poultry, SE infection leads to persistent infection, growth loss, and death, resulting in significant economic losses (Kogut and Arsenault, 2015) . Thus, measures to decrease Salmonella prevalence in C 2018 Poultry Science Association Inc. Received December 20, 2017 . Accepted March 12, 2018 Corresponding author: wangzh@cau.edu.cn poultry are being continuously sought. Various prophylactic measures have been employed to control Salmonella infection in poultry production, including cleaning up the breeding herbs, strict hygienic standards and biosecurity measures, the use of antibiotics, probiotics, organic acids, short-and -medium-chain fatty acids, essential oils, yeast cell wall extract and bacteriophages, genetic selection of chicken lines with improved immunity, and the application of vaccines (Vandeplas et al., 2010; Berge and Wierup, 2012) . Due to the emergence of antibiotic-resistant bacteria and antibiotic residues in poultry products, the search for effective alternatives to antimicrobials in poultry feed has intensified in recent years, spurred on by consumer pressure (Crhanova et al., 2011) .
One of the possible measures targeting a decrease in the prevalence of S. enterica in poultry is probiotics. Probiotics are defined as living or dead microorganisms that exert a beneficial effect on the immune function, intestinal microbiology, or physiology of the host when ingested in sufficient amounts (Gill and Prasad, 2008) . Most studies have showed that probiotics possess various biological functions, such as improving nutrient digestibility and absorption, modulating the intestinal microbiota balance, stabilizing intestinal barrier integrity, defending against enteropathogen adhesion and invasion, and stimulating host cellular and humoral immune responses (Patterson and Burkholder, 2003; Lutful Kabir, 2009; Chaucheyras-Durand and Durand, 2010; Sanders et al., 2013; van Baarlen et al., 2013; Prado-Rebolledo et al., 2017) . Broilers-fed diets with single strain or multispecies probiotics have proven to be effective in reducing Salmonella infection and colonization in poultry (La Ragione and Woodward, 2003; Higgins et al., 2007a,b; Haghighi et al., 2008; Higgins et al., 2008; Higgins et al., 2010; Knap et al., 2011; Shivaramaiah et al., 2011; Thirabunyanon and Thongwittaya, 2012; Yang et al., 2014; Penha Filho et al., 2015; Sadeghi et al., 2015; Upadhaya et al., 2016) . Therefore, probiotics may provide a potential alternative to the prophylactic use of drugs for SE prevention in poultry.
Bacillus coagulans is a safe, unique Gram-positive, spore-forming, microaerophilic, lactic acid producing bacillus that does not encode enterotoxin. It possesses a protective, spore-like protein coating, which allows it to resist high temperature and to survive stomach acid and bile salts, reach the small intestine, germinate, and multiply (Cavazzoni et al., 1998; Endres et al., 2009; Gu et al., 2015) . Hence, it has been used as a probiotic in pig (Adami and Cavazzoni, 1999) and poultry (Cavazzoni et al., 1998; Wang and Gu, 2010 ) production. Previous studies have showed that Bacillus coagulans modified gastrointestinal microbial ecology by replenishing the quantity of desirable obligate microorganisms and antagonizing pathogenic microbes in pig (Adami and Cavazzoni, 1999) and human (Nyangale et al., 2015) , improving growth performance and increased feed digestibility in poultry via secreting enzyme protease, a-amylase, xylanase and lipidase, and producing amino acids and vitamins (Cavazzoni et al., 1998; Wang and Gu, 2010; Zhou et al., 2010) . Administration of Bacillus coagulans to mammal's diets reduced gut inflammation (Kalman et al., 2009; Fitzpatrick et al., 2011; Fitzpatrick et al., 2012; Fitzpatrick, 2013) . In vivo studies using man as model indicated that Bacillus coagulans exhibits antimicrobial, antiviral, and antioxidant activity by modulating cytokines, inhibiting reactive oxygen species, and enhancing phagocytosis (Dolin, 2009; Sari et al., 2011) . In vitro studies have shown that Bacillus coagulans modulated immune responses (Jensen et al., 2010) , and had the ability to produce bacteriocin, bacteriocin-like substances (coagulin) and L-lactic acids with broad activity against various strains of Salmonella, Coliform and Listeria monocytogenes, and Clostridium species (Hyronimus et al., 1998; Le Marrec et al., 2000; Riazi et al., 2009; Honda et al., 2011; Ou et al., 2011; Abdhul et al., 2015; Gu et al., 2015) . Thus, Bacillus coagulans has the potential to control farm animal pathogens. Although some reports have demonstrated that Bacillus coagulans had a growth-promoting effect in poultry reared in unchallenged environment (Cavazzoni et al., 1998; Wang and Gu, 2010; Zhou et al., 2010) , to date, there were no published studies conducted in broiler chickens to examine dietary Bacillus coagulans supplementation as an antibiotic alternative on Salmonella-induced immune responses. Therefore, the objective of the present research was to evaluate the efficacy of Bacillus coagulans in controlling SE infection in broiler chickens by determining its effects on growth performance, cecal microbial populations and liver Salmonella carrier load, intestinal morphological changes, and immune responses in broilers challenged with SE.
MATERIALS AND METHODS

Animal Ethics Statement
All animal experiments were approved by the China Agricultural University Animal Care and Use Committee, Beijing, P. R. China.
Experimental Design and Animal Management
Two hundred and forty 1-d-old Salmonella-free male broiler chickens (Cobb) were purchased from a local supplier (Beijing Arbor Acres Poultry Breeding Company, Beijing, China). Birds were used to evaluate the protective efficacy of Bacillus coagulans feed supplementation against SE infection. To confirm that birds were free from contaminating Salmonella prior to infection, cloacal and fecal samples after hatching were taken from all the birds and tested for the presence of SE in the laboratory (Poultry Microbiological Lab, China Agricultural University, Beijing, China). Samples were pre-enriched with tetrathionate broth (CM 203-01, Land Bridge Technology Ltd., Beijing, China) at 37
• C for 24 h, and then streaked on Bismuth sulfite agar (CM 207, Land Bridge Technology Ltd.) to confirm that the chicks were free of SE. Subsequently the chicks were randomly divided into 4 experimental groups. The treatment groups were as follows: group 1, control diet, uninfected; group 2, control diet, infected with S. enteritidis; group 3, Bacillus coagulans-supplemented diet, uninfected; group 4, Bacillus coagulans-supplemented diet, infected with S. enteritidis. Each group contained 6 replicate pens with 10 birds per pen and fed a balanced, unmedicated corn and soybean meal-based mash diet that contained either 0 (control) or 400 mg/kg Bacillus coagulans. To avoid cross-contamination, all uninfected birds (group 1 and group 3) were reared in one separate room, whereas all infected birds (group 2 and group 4) were housed in another room under the same environmental conditions. Bacillus coagulans used in the experiments was provided by Lifeed Biological Co. Ltd (Zhuzhou City, Hunan Province, China). Antibiotic-free and coccidiostat-free cornsoybean meal-based mash diets were formulated to meet or exceed National Research Council (1994) requirements. The composition of the basal diet and nutrient levels are presented in Table 1 . The experimental diet was formulated by mixing the basal diet with 400 mg of Bacillus coagulans (1 × 10 10 CFU/g of the product) to reach 4 × 10 9 CFU/kg of diet. To ensure the homogeneity of the additives, approximately 5 kg of the basal diet mixed with the additive were thoroughly mixed using a plastic bucket. Prior to the experiments, feed samples were collected and checked for the presence of Salmonella by bacterial culture as described above.
The room temperature was maintained at 32 • C to 34
• C during the first 5 d and then gradually decreased by 2
• C/wk to reach a final room temperature of 22 • C to 24
• C. Chickens had free access to feed and water, and were housed in wire cages, received continuous light for the first 24 h, and were then maintained under 23L:1D for the remainder of the study.
SE Challenge
The Salmonella enteritis serotype CVCC3379 was obtained from the China Veterinary Culture Collection Center, the China Institute of Veterinary Drug Control (Beijing, China). The frozen culture was recovered by using sterile buffered peptone water (CM201, BPW, Land Bridge Technology Ltd.). Salmonella enteritidis pre-culture was transferred to 100 mL of tryptone soy broth (CM201, TSB, Land Bridge Technology Ltd.) and incubated at 37
• C with orbital shaking for 16 to 18 h. To determine the concentration of viable SE in the culture, the inoculum was diluted with sterile phosphate buffered saline (PBS, pH 7.2) and plated on Bismuth sulfite agar and incubated at 37
• C for 24 h. The colonies were counted and the stock culture was adjusted to a final SE concentration of 1 × 10 9 CFU/mL SE. At 9 to 11 d of age, birds in the SE-challenged groups were administered 1 mL of bacterial suspension containing approximately 10 9 colony forming units (CFU) of SE suspension by gavage. Unchallenged groups received 1.0 mL of PBS without SE on the same date. Feed was withdrawn from all birds 10 h before challenge and returned immediately after SE challenge.
Sample Collection
Birds and feed intake (FI) were group weighed by cage at 1, 9, 15, 22, and 42 d of age. Average body weight gain (BWG), average FI, and feed conversion ratio (FCR) were calculated for each period and for the overall experiment. These performance parameters were corrected according to mortality.
At 7, 17, and 31 days post infection (DPI), 6 birds from each group were randomly selected, weighed, and then wing venous blood were collected in 10-mL tubes and centrifuged at 2,000 × g for 15 min at room temperature. Serum samples were harvested and stored at −20
• C for Salmonella-specific IgG analysis. These birds were euthanized by cervical dislocation and approximately 1 cm of jejunum samples between Meckel's diverticulum to the proximal jejunum of each bird were collected in RNAlater RNA stabilization agent (Qiagen, Germantown, MD) at 4
• C for no less than 24 h and directly snap-frozen in liquid nitrogen and stored at -80
• C for mRNA determination. Samples of the jejunum, approximately 2 cm in length midway between the endpoint of the duodenal loop and Meckel's diverticulum, were collected, washed in physiological saline solution, and fixed in 10% neutral buffered formalin solution overnight for histological examination. Jejunal mucosa from each bird was collected in 5 mL of protease inhibitor cocktail containing 0.3 mg/mL EDTA, 75 μg/mL phenylmethylsulfonyl fluoride (PMSF), 0.7 μg/mL pepstatin, and 0.5 μg/mL leupeptin (Sigma-Aldrich, St. Louis, MO), with ice-cold PBS (pH 7.2). The supernatant was collected after centrifugation at 10,000 × g for 10 min at 4
• C and stored at -20
• C until determination of Salmonella-specific IgA antibodies. The cecal contents of each killed bird were collected and frozen immediately at −40
• C until further analysis for bacterial populations.
Gut Histological Analysis
Gut histomorphology and goblet cells analysis were performed as previously described (Shao et al., 2013) . The fixed tissue samples were dehydrated in a tissue processor (Leica Microsystems K. K., Tokyo, Japan) and embedded in paraffin wax. Paraffin sections (5 μm) were sliced using a microtome (Leica Microsystems K. K., Tokyo, Japan) and mounted on glass slides. The paraffin was removed using xylene (2 times for 5 min each), followed by rehydration in isopropylene (5 min), 95% alcohol (5 min), and 50% alcohol (5 min). Sections were stained with haematoxylin and eosin for histological analysis, and periodic acid-Schiff staining for goblet cell visualization and measurement. Measured variables included villus height, crypt depth, and goblet cell number per villus as described previously (Shao et al., 2013) . For each parameter, at least 15 replicate measurements were taken per bird and the average of these values was used in statistical analysis.
Microbiological Analysis
The caecal microflora was analyzed using the culture technique as described previously (Shao et al., 2013) . Approximately 1 g of each sample (cecal digesta and liver samples) was aseptically placed into preweighed 15-mL sterile plastic tubes (Corning Inc., Beijing, China), weighed, and diluted with sterile buffered peptone water (CM201, Land Bridge Technology Ltd.) to an initial 10 −1 dilution, and the tube contents homogenized separately using a Heidolph Diax 600 homogenizer (Heidolph, Schwabach, Germany) for 30 s. These homogenized solutions of each sample were then serially diluted in 0.85% sterile saline solution from 10 −1 to 10 −7 , and 100 μL of each diluted sample was subsequently plated on selective agar plates for bacteria counting in duplicate.
Coliform bacteria were cultured using MacConkey agar (CM908; Beijing Land Bridge Technology Co., Ltd.) after aerobic incubation at 37
• C for 24 h. Lactobacilli concentrations were determined using lactobacilli de Man, Rogosa, and Sharpe agar MRS agar (CM 188, Land Bridge Technology Ltd.), and incubated at 37
• C for 48 h. Bifidobacterium colonies were counted on Bifidobacterium agar (CM194; Beijing Land Bridge Technology Co., Ltd.) after incubation in an anaerobic cabinet at 39
• C for 48 h. Salmonella counts in cecal contents were determined using xyloselysine-deoxycholate agar (XLD; CM 219, Land Bridge Technology Ltd.) after aerobic incubation at 37
• C for 24 h. The liver Salmonella was evaluated by counting Salmonella colonies on XLD agar. Negative samples were placed in tetrathionate broth (1:10, TTB, CM203-01, Land Bridge Technology Ltd.), incubated at 37
• C for 24 h, and streaked on XLD agar. The number of CFU was counted and expressed as a logarithmic (log 10 ) values per gram of intestinal digesta or liver tissue.
Determination of Intestinal Alkaline Phosphatase Activity
Previously frozen jejunal tissue samples were thawed on ice and 350 mg of each tissue was homogenized in 7 mL of 50 mM cold PBS (pH 7.4) containing 0.5% Triton X-100. The resulting homogenate was then centrifuged at 10,000 × g (Sorvall Legend 23R, Thermo Fisher Scientific Inc., Waltham, MA) for 15 min, and the supernatant was collected for estimation of protein (A-045-2, Total Protein Quantitative Assay kit, Nanjing Jiancheng Bioengineering Institute, Nanjing, China) and ALP activity (A-059-2, Alkaline Phosphatase Assay (IAP) Kit, Nanjing Jiancheng Bioengineering Institute, Nanjing, China). The assay used stable p-nitrophenol phosphate (pNPP) as a substrate. Each sample was normalized by the total protein content to determine specific activity. Total IAP activity was expressed as nmoles pNPP hydrolysed/min/mg protein.
Measurement of Anti-Salmonella Specific Antibody in the Intestine and Serum
The levels of intestinal mucosa and serum anti-SE antibodies were measured by an ELISA as previously described with some modifications (Shao et al., 2016) . Salmonella enteritidis CVCC 3379 (10 8 CFU/mL) cells were washed and used to prepare the soluble antigen using 8 cycles of sonication (an ultrasonic homogenizers, Biologics Inc., Manassas Virginia, USA) at 85 Watts and 30-s intervals on ice. After each step, reagents were removed by aspiration, and wells were washed with 200 μL of PBS containing 0.1% Tween 20 (PBST) 3 times using an automatic ELISA plate washer (BioTek ELX 405 microplate washer, Bio-Tek Instruments, Winooski, VT). Diluted antigen (20 to 40 μg/mL in carbonate-bicarbonate buffer pH 9.6, 15 mM Na 2 CO 3 , 35 mM NaHCO 3 , 0.3 mM NaN 3 ) was added to wells of 96-well flexible polyvinyl ELISA microplates (Corning, NY) and incubated over night at 4
• C. The antigen solution was removed and the wells were blocked with PBS buffer (pH 7.4) containing 1% BSA for 1 h at 37
• C to block nonspecific binding. Serum samples were diluted 1:100 and intestinal samples were diluted 1:5 in PBST with 1% BSA. Hundred microliters of diluted serum samples or intestinal mucosa supernatant were added to wells and incubated for 1 h at 37
• C. Either horseradish peroxidase-conjugated goat anti-chicken IgG (A30-104P, Bethyl Laboratories Inc., Montgomery, TX) diluted 1:10,000 in PBST for serum anti-SE specific IgG analysis or goat anti-chicken IgA Fc HRP conjugate (A30-103P, Bethyl Laboratories Inc., Montgomery, TX) diluted 1: 20,000 in PBST for intestinal anti-SE specific IgA determination were added to wells, and incubated for 1 h at 37
• C. The plates were washed 5 times with PBST and incubated with 3,3 , 5,5 -tetramethylbenzidine (TMB) for 30 min at room temperature in the dark. The reaction was stopped by using sulfuric acid, and the absorbance was measured at 450 nm using an automatic ELISA reader (Bio-Tek EL311SX, Bio-Tek, USA). Each serum sample or intestinal sample was tested in duplicate.
Quantitative Real-Time PCR for Measuring Immune-Related Gene Transcript Levels in the Jejunum
Total RNA was isolated from snap-frozen jejunal tissue samples (50 mg) according to the RNeasy mini kit following the animal tissue protocol (Qiagen, Germantown, MD). The purity and concentration of the total RNA were measured in a spectrophotometer (NanoDrop-2000, Thermo Fisher Scientific) using the 260:280 nm absorbance ratio. Ratios of absorption (OD 260 /OD 280 ) of all samples ranged between 1.8 and 2.0. First-strand cDNA was synthesized from 2 μg of total RNA using a Primer Script RT reagent Kit with gDNA Eraser (Perfect Real Time; Takara Biotechnology Co. Ltd., Tokyo, Beijing, China) according to the manufacturer's instructions and stored at -20
• C until further processing. Oligonucleotide primers for chicken TLR2, TLR4, TNFSF15, IFN-r, LYZ, Fowlicidin-2, mucin-2, and chicken glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ( Table 2) were designed based upon sequences available from public databases using the Primer Express 3.0 software (Applied Biosystems, Foster City, CA) and synthesized by Invitrogen (Shanghai). Primers were designed to span an intron to avoid genomic DNA amplification. Quantitative realtime PCR was performed using the Applied Biosystems 7500 Fast Real-Time PCR System and an SYBR Premix Ex Taq kit (Takara Biotechnology Co. Ltd., Beijing, China). Reactions were performed in a 20-μL reaction mixture containing 10.0 μL of SYBR Premix Ex Taq (2 ×) mix, 1.0 μL of cDNA, 0.5 μL of each primer (10 mM), and 8.0 μL of sterile nuclease-free water. For PCR, samples were subjected to an initial denaturation phase at 95
• C for 5 min followed by 40 cycles of denaturation at 95
• C for 30 s and annealing and extension at 60
• C for 30 s. Melt curve was performed to confirm the amplification specificity of the PCR. All the tissue samples for the cDNA synthesis and in the following PCR amplifications were analyzed in triplicate. Gene expressions for TLR2, TLR4, TNFSF15, IFN-γ, LYZ, Fowlicidin-2, and mucin-2 were analyzed using GAPDH as an endogenous control. Average gene expression relative to the GAPDH endogenous control for each sample was calculated using the 2 −ΔΔCt method (Livak and Schmittgen, 2001 ). The fold change in the target gene relative to GAPDH was determined with the following formula: fold change = E −ΔΔCT , where ΔΔCT = (Ct target gene −Ct GAPDH ).
Statistical Analysis
Data were analyzed by the GLM procedure of SPSS 17.0 (SPSS Inc., Chicago, IL) as a 2 × 2 factorial arrangement (2 levels of Bacillus coagulans treatment and 2 levels of SE challenge). The main effects of Bacillus coagulans and SE challenge and the associated twoway interactive effects were analyzed. Duncan's multiple comparisons test was used to separate means when interactive effects differed significantly. Results are expressed as treatment means with their pooled SEM. A P value of ≤0.05 was considered to be statistically significant and P values between 0.05 and 0.10 were classified as trends.
RESULTS
Performance Parameters
The growth performance of chickens at different ages is presented in Table 3 . Salmonella enteritidis infection did not significantly affect FI, BWG, and feed Means with different superscripts in the same column differ significantly (P < 0.05).
1 FCR= feed conversion ratio = g of feed intake/g of BW gain, g/g.
2 SE =challenged with Salmonella enteritidis; −, without SE challenge; +, with SE challenge.
3 SEM, standard error of the mean.
4
P-values represent the main effect of the diet, the main effect of SE challenge, and the interaction between the dietary treatments and SE challenge.
convertible ratio (FCR) of chicks at the different time periods (P > 0.05) compared to uninfected birds. Broilers supplemented with Bacillus coagulans only showed higher BWG (P = 0.024) and FCR (P = 0.044) on d 15 to 21 compared to non-supplemented birds. No significant differences were observed in mortality percentages between treatment groups at all time periods (data not shown). In addition, there was no significant interaction (P > 0.05) in growth performance between SE challenge and Bacillus coagulans supplementation.
Intestinal Morphology and Goblet Cell Numbers
Salmonella enteritidis infection significantly reduced goblet cell numbers at 7 DPI (P = 0.009), and showed a decreasing trend in villous height (at 7 DPI, P = 0.082) and villous: crypt ratio (at 7 DPI, P = 0.086) in the small intestine of the SE-challenged birds alone compared with the uninfected birds. Chickens receiving Bacillus coagulans diets showed lower crypt depth at 17 DPI (P = 0.011), higher villous: crypt ratios at 17 DPI (P = 0.032), and goblet cell numbers at 7 and 17 DPI (P = 0.037; P = 0.001) in the jejunum compared with the non-supplemented group (Table 4) . Furthermore, birds-fed diets supplemented with Bacillus coagulans also showed a trend of increased villous height to crypt depth ratio in the jejunum at 7 DPI (P = 0.060) compared to the non-supplemented birds. There was no significant interaction effect for intestinal morphology and goblet cell numbers between SE infection and Bacillus coagulans addition.
Caecal Bacterial Colonization and Liver Salmonella Invasion
Salmonella enteritidis infection significantly decreased the population of Lactobacilli at 7 DPI (P < 0.001) and Bifidobacterium at 31 DPI (P = 0.021) in cecal contents, but significantly increased cecal Escherichia coli (at 7, 17, and 31 DPI) and Salmonella (at 7 and 17 DPI) counts (P < 0.05), and there was a trend for cecal Salmonella levels at 31 DPI compared with the uninfected birds. However, chickens-fed diets with Bacillus coagulans showed significantly higher Lactobacilli and Bifidobacterium numbers at 7 and 17 DPI, lower coliform (at 7, 17, and 31 DPI) and Salmonella (at 7 and 17 DPI) concentration (P < 0.05) in the cecum (Table 5) in comparison with the non-supplemented birds.
In addition, SE infection significantly increased Salmonella numbers in the liver at 7, 17, and 31 DPI (P < 0.05). However, the addition of Bacillus coagulans to the feed tended to reduce Salmonella colony loads in the liver of the chicks at 7, 17, and 31 DPI (0.05 < P < 0.10) as compared to the non-supplemented chicks. There was no significant interaction effect in bacterial 
Anti-Salmonella Specific IgA and IgG Concentrations and Intestinal Alkaline Phosphatase Activity
No significant cooperative effect was observed between Bacillus coagulans supplementation and SE infection in terms of serum-specific IgG, jejunal-specific secretary IgA concentration, and intestinal alkaline phosphatase (IAP) activity of broilers (Table 6 ). Compared with the uninfected birds, SE infection significantly elevated the concentration of jejunal antiSalmonella-specific IgA at 17 DPI (P = 0.021), and sera anti-Salmonella-specific IgG at 7 and 17 DPI (P = 0.043; P = 0.046). In addition, Bacillus coagulans inclusion only increased IAP activity in the jejunum of broilers at 7 DPI (P = 0.043), but there were no significant effects on anti-Salmonella IgA concentrations in the jejunum and serum anti-Salmonella IgG concentrations at different sampling time-point when compared with the non-supplemented birds.
TLRs, Cytokines, Mucin-2 and Fowlicidin-2 mRNA Expression in the Jejunum
Changes in the mRNA expression of TLR in the foregut are shown in Table 7 . No significant interaction effects were observed for TLR2, TLR4, cytokines, mucin-2, and Fowlicidin-2 mRNA expression between SE infection and Bacillus coagulans addition. As compared with the uninfected birds, SE infection significantly (P < 0.05) decreased mucin-2 (at 7 and 17 DPI), TLR2 (at 7 and 17 DPI), TLR4 (at 17 DPI), and TN-FSF15 (at 7 and 17 DPI) gene mRNA levels, but significantly increased IFN-r mRNA levels (at 17 DPI, P = 0.001), and showed a reduced trend for TLR4 and Fowlicidin-2 gene mRNA levels (at 7 DPI). Compared with the non-supplemented group, supplementation of Bacillus coagulans significantly upregulated the expression of LYZ mRNA at 17.DPI (P = 0.016), significantly downregulated IFN-r mRNA levels at 7 and 17 DPI (P = 0.007; P = 0.036), had an increased trend for Fowlicidin-2 mRNA levels (at 7 DPI, P = 0.099), but had no significant effects on mucin-2, TLR2, TLR4, and TNFSF15 mRNA levels in the intestine of broilers during the entire experimental period.
DISCUSSION
In the current study, birds-fed diets with Bacillus coagulans supplementation displayed a growth-promoting effect and improved FCR during the starter stage regardless of SE challenge compared with the nonsupplemented birds. This was in agreement with findings from most other studies showing that the use of the probiotic, Bacillus coagulans, has a positive effect on the growth performance of broilers (Cavazzoni et al., 1998; Wang and Gu, 2010; Zhou et al., 2010; Hung et al., 2012) . The reasons for the improvement in BWG and FCR of broilers fed a probiotic Bacillus coagulans product supplement were probably due P-values represent the main effect of the diet, the main effect of SE challenge, and the interaction between the dietary treatments and SE challenge.
to the increased feed consumption, or the improved nutrient digestibility via promoting secretion of endogenous enzymes . Another possible reason for Bacillus coagulans supplement improving growth performance is that Bacillus coagulans also produces some exoenzyme such as amylase, protease and lipase, vitamins, amino acids, and some unknown growth-promoting factors by directly fermenting in the gut, and then increases small intestine peristalsis, improves feed digestibility and availability, and promotes gut health (Cartman et al., 2008; Gu et al., 2015) .
Intestinal morphology, including villus height and crypt depth, as well as villus height to crypt depth ratio, intestinal microbiota balance and intestinal bacterial translocation rate are important indices of intestinal health, recovery and function. In this study, birds infected with SE exhibited damaged gut morphological structure, reduced jejunal goblet cell numbers, cecal bacterial dysbiosis, and higher Salmonella invasion of the liver compared with the uninfected birds, suggesting that SE infection exerts a harmful effect on gut health. However, chickens receiving Bacillus coagulanssupplemented diets not only showed improved gut morphology and increased goblet cell numbers in the jejunum, but the growth of beneficial bacteria prevented harmful bacteria colonization, reducing the levels of Salmonella in the livers of the chickens, regardless of SE challenge, indicating that supplementing Bacillus coagulans exerted a positive role in controlling Salmonella infection. Also consistent with our results, some other studies have reported that Bacillus coagulans benefits the ecosystem of the intestinal tract in chickens (Hung et al., 2012) and pigs (Adami and Cavazzoni, 1999) . Likely mechanisms by which administration of Bacillus coagulans decreased cecum colonization of chicks by pathogens includes exclusion through competition for receptor sites, the production of volatile fatty acids that are inhibitory to certain enteric pathogens, the production of bacteriocins, competition with pathogens and native flora for limiting nutrients, or stimulation of a host innate immune response (Hyronimus et al., 1998; Le Marrec et al., 2000; Dolin, 2009; Riazi et al., 2009; Honda et al., 2011; Ou et al., 2011; Sari et al., 2011; Abdhul et al., 2015; Gu et al., 2015) . Bacillus coagulans may also increase intestinal barrier integrity (Prado-Rebolledo et al., 2017) , and several studies have suggested that it may improve gut morphology (Dolin, 2009; Fitzpatrick, 2013) as confirmed in this study. Based on our results, oral administration of Bacillus coagulans appears to have a positive effect in combating Salmonella infection and maintaining gut health in chickens. It has been noted previously that the intestinal microbial composition and intestinal morphological structure are correlated with energy transport and metabolism capability of the gut and the performance of the bird (Torok et al., 2008) . Therefore, improved growth in birds receiving Bacillus coagulans diets may be associated with improved gut structure and microbiota ecology. IAP is an endogenous protein expressed by the intestinal epithelium that is also believed to play a vital role in maintaining gut development and maturation, gut homeostasis and health through interactions with the resident microbiota, diet, and the gut (Estaki et al., 2014) . Loss of IAP expression or function is associated with increased intestinal inflammation, dysbiosis, injured intestinal barrier structure, bacterial translocation, and subsequently systemic inflammation (Fawley and Gourlay, 2016) . Therefore, maintaining or stimulating IAP activity by dietary intervention is a goal for preserving gut homeostasis and health by minimizing low-grade inflammation. In this study, enhanced IAP activity was observed in the jejunum of the Bacillus coagulans-supplemented birds, implying that Bacillus coagulans had the ability to ameliorate SE-caused intestinal inflammation as well as maintain gut health by stimulating intestinal IAP activity (Malo et al., 2010) . Increased intestinal IAP activity may also contribute to increased BWG and improved FCR in the Bacillus coagulans-treated birds.
The avian innate immune system comprises a wide spectrum of defense mechanisms against invading pathogens and consists of a variety of immune effector cells, enzymes (lysozyme), proteins and peptides, including the host defense peptides (HDP) that function as a first line of defense, HDP (defensins and cathelicidins) and LYZ have a wide range of antimicrobial activity against different groups of microorganisms (Cuperus et al., 2013) .In this study, a remarkable upregulation in LYZ gene expression and an increasing trend in intestinal Fowlicidin-2 gene mRNA levels were observed in birds fed with Bacillus coagulans compared with un-supplemented birds, indicating that feeding Bacillus coagulans was able to activate innate immunity in chickens. Bacillus-based probiotics have been reported to enhance innate immune function by promoting the synthesis of endogenous antimicrobial peptides in the gut (Hong et al., 2005; Akbari et al., 2008) or augment macrophage function by increasing serum NO production . The upregulation of these innate immune-related genes in the probioticstreated group may be the results of inhibitory effects of Bacillus coagulans on Salmonella colonization and invasion in chickens.
Specific antibody in plasma and intestinal mucosal tissue may help block the invasion and spread of Salmonella (Chappell et al., 2009; Jawale and Lee, 2014; Holmgren and Czerkinsky, 2005) . Increased circulating and secretory antibodies were detected during SE infection in our study suggesting that the humoral response may also be an important component in protective immunity (Jawale and Lee, 2014) . Some studies have indicated that Bacillus spp. could increase chicken systemic or intestinal mucosal humoral immunity, enhancing the disease resistance capacity in chickens (Haghighi et al., 2005; Haghighi et al., 2006; Sadeghi et al., 2015; Alizadeh et al., 2017) . However, we did not observe any significant change in anti-Salmonella IgA concentrations in the jejunum and serum anti-Salmonella IgG concentrations at different sampling time-points when chickens were treated with Bacillus coagulans. Similar findings have been reported in broiler chickens that had received probiotics products (Haghighi et al., 2005) . One possible reason was that a reduction in Salmonella numbers in the intestine and liver of the chickens-fed Bacillus coagulans via competitive exclusion reduced a strong local or systemic immune response, or Salmonella infection early in life may hamper the ability of young chicks to mount an effective immune response against the invading pathogen (Holt et al., 1999; Kogut et al., 2016) . This result also implies that the continuous addition of dietary Bacillus coagulans decreased host immune inflammatory response induced by Salmonella, as a consequence of the exclusion of potentially harmful microbiota by Bacillus coagulans during the later infection period.
Toll-like receptors (TLR) play a crucial role in the defense against pathogens by activating the transcription factor NF-κB signaling pathway and induction of inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), interleukins (IL-6, IL-1β, IL-8, and IL-12), interferon (IFN), and co-stimulatory molecules (Akira and Takeda, 2004) . Many studies have demonstrated that S. enteritidis infection resulted in the increased expression of proinflammatory cytokines (IFN-γ, IL-1β, and IL-6) and TLR signals (TLR2, TLR4, TLR5, TLR6, TLR15, and TLR21) in the spleen and cecum of broiler chickens during the early stage of infection (Kaiser et al., 2000; Kogut et al., 2005; Takeda and Akira, 2005; Cheeseman et al., 2007; Dougan et al., 2011; Setta et al., 2012; Rychlik et al., 2014) . In the present study, SE infection significantly increased proinflammatory cytokine IFN-γ mRNA levels compared with the unchallenged control, suggesting SE challenge induced an intestinal Th1 inflammatory response. Interestingly, decreased TLR2, TLR4, and TN-FSF15 and Fowlicidin-2 gene mRNA levels at the middle and later phases after SE infection were observed in the jejunum of the SE-infected birds alone in our study. Similar results also were reported by some researchers (Nerren et al., 2009; Kogut et al., 2016) . We speculate that the Salmonella established itself as a persistent cecal infection, part of the normal microbiome of the cecum, was no longer recognized by the host immune system, or induced immunosuppression during the later infection with SE (Johnston et al., 2012; Kogut and Arsenault, 2015; Kogut et al., 2016) . On the other hand, Bacillus coagulans-fed birds displayed no significant effects on TLR2, TLR4, and TNFSF15 gene mRNA levels in the intestine of broilers at any of the time periods compared with non-supplemented controls, showing that Bacillus coagulans has the potential to suppress intestinal inflammation or did not induce immune inflammatory responses or activate TLRmediated signal pathway responses in the intestine. It is also intriguing that during the latent stage of infection, downregulated expression of the proinflammatory cytokine IFN-γ in the intestine of Bacillus coagulansfed chickens correlated with the lower SE burden in the cecum regardless of SE infection, indicating that oral administration of Bacillus coagulans either mitigates intestinal inflammation or increases the ability of the host to clear the Salmonella. Similarly, repression of IFN-γ and increase of IL-12 gene expression were Table 7 . Effect of Bacillus coagulans on immune-related gene expressions in the jejunum of broilers challenged with SE (n = 6). Means with different superscripts in the same column differ significantly (P < 0.05).
1 DPI = days post infection.
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reported to be associated with the reduction of intestinal Salmonella colonization (Sadeyen et al., 2004; Haghighi et al., 2008) . Furthermore, previous studies have showed that Bacillus coagulans reduced intestinal inflammation in mice by downregulating expression of intestinal cytokines (Jensen et al., 2010; Abhari et al., 2016) . Thus, it is also possible that the reduced intestinal inflammatory response caused by Bacillus coagulans could lead to an increase in the intestinal health of broiler chickens, resulting in a savings of energy usage for growth and maintenance (Wang and Ye, 2015) . In summary, Bacillus coagulans supplementation appears to be effective at reducing Salmonella enteritidis prevalence in broilers by improving intestinal morphology, regulating intestinal mucosal immune responses as well as inhibiting harmful intestinal bacterial colonization and invasion in chickens, without impairing growth performance. Bacillus coagulans can be used as an intervention strategy to reduce Salmonella infection in broiler production. However, further studies are needed to fully understand the protective effects of dietary Bacillus coagulans supplementation on Salmonella challenges.
